Since its inception, SAA has been committed to research, from funding scientific meetings to launching the first genetic research study in the United States on ankylosing spondylitis and related diseases. SAA continuously supports innovative research and researchers. As an early leader in the quest for a cure, SAA has funded a spondyloarthritis patient registry, studies on the microbiome in spondyloarthritis, life impact studies, as well as health care professional educational CME programs such as the MRI (magnetic resonance imaging) program to help radiologists and rheumatologists work together to hasten diagnosis.